ERYTECH Announces Enrollment of First Patient in Phase I/II Study of ERY-ASP in Acute Lymphoblastic Leukemia in the United States | Business Wire | Bioscience News - GEG Tech top picks | Scoop.it
From www.businesswire.com - July 23, 2014 10:16 AM
Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative &lsq